Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

CDRH Seeks Stakeholder Input on 2019 Guidance Priorities

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

FDA’s Center for Devices and Radiological Health called for feedback from stakeholders on its priorities for developing guidance for the year ahead. Source: The GMP Letter

Continue ReadingCDRH Seeks Stakeholder Input on 2019 Guidance Priorities

Health Canada Maps Out Action Plan to Improve Device Safety, Quality

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

Health Canada released a three-part action plan aimed at improving how devices get on the market, strengthening monitoring and providing more information to consumers about the devices they use. Source:…

Continue ReadingHealth Canada Maps Out Action Plan to Improve Device Safety, Quality

Notified Bodies Warn of Future Bottlenecks in Implementing New Device Regs

  • Post author:Sam
  • Post published:February 8, 2019
  • Post category:The GMP Letter

The European Association for Medical Devices of Notified Bodies (Team-NB) is sounding alarms over the shortage of notified bodies to conduct audits and certify devicemakers in time to comply with…

Continue ReadingNotified Bodies Warn of Future Bottlenecks in Implementing New Device Regs

Controls Found Lacking at Contract Manufacturer Thatcher

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

Contract manufacturer Thatcher Company failed to exercise appropriate controls over computers and related systems to assure that changes in production were only instituted by authorized personnel, FDA inspectors found during…

Continue ReadingControls Found Lacking at Contract Manufacturer Thatcher

Surgical Instruments Maker Racks Up 11-Item 483

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

Lax medical device reporting and CAPA procedures as well as a host of other quality issues were uncovered during a July 31 to Aug. 2 FDA inspection of LED Intellectual…

Continue ReadingSurgical Instruments Maker Racks Up 11-Item 483

Texas Neonatal Devicemaker Falls Short on Process Controls

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

FDA inspectors found shoddy process controls and a lack of validation documentation in a Sept. 17 to Sept. 21 inspection of Footprint Medical’s San Antonio, Texas facility. Source: The GMP…

Continue ReadingTexas Neonatal Devicemaker Falls Short on Process Controls

Canada Issues Guidance on Cybersecurity Requirements

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

Health Canada released guidance for devicemakers on how to comply with premarket cybersecurity requirements. Source: The GMP Letter

Continue ReadingCanada Issues Guidance on Cybersecurity Requirements

Device Groups Reject Media Reports of Inadequate Oversight

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

International medical device associations rejected a recent report by the International Consortium of Investigative Journalists (ICIJ), which pointed to inadequate oversight of devices globally. Source: The GMP Letter

Continue ReadingDevice Groups Reject Media Reports of Inadequate Oversight

FDA Unveils Guidance on Diagnostic X-Ray Equipment

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

The FDA issued draft guidance to clarify radiation control regulations for diagnostic x-ray systems and their major components, including recordkeeping, reporting, manufacturing, importing and installation requirements for “electronic products.” Source:…

Continue ReadingFDA Unveils Guidance on Diagnostic X-Ray Equipment

FDA Warns MiBo Medical for Design Controls, CAPAs

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

Seven months after issuing a Form 483 to MiBo Medical Group following an inspection of its Dallas, Texas facility, the FDA warned the devicemaker that it had not fully addressed…

Continue ReadingFDA Warns MiBo Medical for Design Controls, CAPAs
  • Go to the previous page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.